Showing results (6501-6510 of 10,080) with videos related to

Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 20, 2009
Role of vascular progenitor cells in cardiovascular diseaseKimie Tanaka, Masataka Sata
Current Pharmaceutical Design|August 20, 2009
Autologous adipose-derived regenerative cells for therapeutic angiogenesisToyoaki Murohara, Satoshi Shintani, Kazuhisa Kondo
Current Pharmaceutical Design|August 20, 2009
Are the pleiotropic effects of telmisartan clinically relevant?C V Rizos, M S Elisaf, E N Liberopoulos
Current Pharmaceutical Design|August 13, 2009
The VHL tumor suppressor: master regulator of HIFVolker H Haase
Current Pharmaceutical Design|August 13, 2009
HIF-1 inhibitors for cancer therapy: from gene expression to drug discoveryG L Semenza
Current Pharmaceutical Design|April 10, 2009
Angiogenesis as risk factor for plaque vulnerabilityRossella Di Stefano, Francesca Felice, Alberto Balbarini
Current Pharmaceutical Design|April 10, 2009
Imaging and laboratory biomarkers in cardiovascular diseaseMaria Grazia Andreassi, Amalia Gastaldelli, Aldo Clerico, et al.
Current Pharmaceutical Design|April 10, 2009
Attenuated D2 16681-PDK53 vaccine: defining humoral and cell-mediated immunityJ Rabablert, S Yoksan
Current Pharmaceutical Design|April 10, 2009
Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancerJ L Ríos, M C Recio, J M Escandell, et al.
Current Pharmaceutical Design|April 10, 2009
The common mycobacterial antigens and their importance in the treatment of diseaseJohn Stanford, Cynthia Stanford, Gerard Stansby, et al.
Pageof 1,008